Beta Thalassemia Market
According to Intent Market Research, the Beta Thalassemia Market is expected to grow from USD 1.0 billion in 2023 at a CAGR of 12.6% to touch USD 2.3 billion by 2030. The Beta Thalassemia Market is dominated by key players such as, Bristol-Myers Squibb Company, Novartis International AG, GlaxoSmithKline Plc, Mylan N.V., and Baxter International Inc.